Metrics to compare | 4128 | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship Relationship4128PeersSector | |
|---|---|---|---|---|
P/E Ratio | −15.3x | −15.6x | 11.5x | |
PEG Ratio | −0.40 | 0.31 | 0.03 | |
Price/Book | 1.2x | 1.8x | 1.5x | |
Price / LTM Sales | 5.5x | 1.4x | 0.9x | |
Upside (Analyst Target) | - | 23.5% | 26.0% | |
Fair Value Upside | Unlock | 13.1% | 14.6% | Unlock |
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and health foods in Taiwan. It provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. The company is also involved in the sale of organic food and beverages; provision of technology development, transfer, and consulting services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was incorporated in 2000 and is based in Taipei, Taiwan.